Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

147.59 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 64,446
Open 147.59
Bid (Size) 146.75 (10)
Ask (Size) 147.15 (5)
Prev. Close 147.59
Today's Range 147.59 - 147.59
52wk Range 144.95 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, with the index futures trading mixed early 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Earnings Scheduled For April 16, 2024
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter. 
Via Benzinga

Performance

YTD
-7.74%
-7.74%
1 Month
-5.85%
-5.85%
3 Month
-8.06%
-8.06%
6 Month
-6.31%
-6.31%
1 Year
-10.91%
-10.91%

More News

Read More
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
From Johnson & Johnson
Via Business Wire
A Closer Look at 9 Analyst Recommendations For Johnson & Johnson
Via Benzinga
Johnson & Johnson Reports Q1 2024 Results
From Johnson & Johnson
Via Business Wire
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Via Talk Markets
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
Via Benzinga
Topics Stocks
Exposures US Equities
J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
From Brodsky & Smith LLC
Via GlobeNewswire
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
Via InvestorPlace
Topics Stocks
Exposures US Equities
MarketBeat Week in Review – 4/8 - 4/12
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Quarterly Releases To Watch Next Week
Via Talk Markets
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
Via The Motley Fool
Topics ETFs
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
Via InvestorPlace
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
Via InvestorPlace
5 Things To Know In Investing This Week - The Shockwave Takeover Issue
Via Benzinga
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
Via InvestorPlace
Rare Disease-Focused Rallybio Inks Development Pact With Johnson & Johnson, Stock Shoots Higher
Via Benzinga
Nike Stock Jumps On Upgrade As Estimates 'Finally Look Achievable' Ahead Of Paris Olympics
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why Is Rallybio (RLYB) Stock Up 93% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.